Noninfectious Endophthalmitis after Intravitreal Injection of Aflibercept.
10.3341/jkos.2016.57.6.1018
- Author:
Chung Hwan KIM
1
;
Ji Soo SHIN
;
Chan Yang JEON
;
Young Suk CHANG
;
Young Hoon LEE
Author Information
1. Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea. astrix001@kyuh.ac.kr
- Publication Type:Case Report
- Keywords:
Intravitreal aflibercept injection;
Noninfectious endophthalmitis
- MeSH:
Aged;
Anterior Chamber;
Anti-Bacterial Agents;
Endophthalmitis*;
Humans;
Inflammation;
Intravitreal Injections*;
Macular Degeneration;
Male;
Ophthalmic Solutions;
Steroids
- From:Journal of the Korean Ophthalmological Society
2016;57(6):1018-1021
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report a case of noninfectious endophthalmitis after intravitreal injection of aflibercept. CASE SUMMARY: A 67-year-old male patient presented with sudden vision loss 2 days after intravitreal aflibercept injection for neovascular age-related macular degeneration. Mild conjunctival injection and moderate inflammation in the anterior chamber were noted, but he had no ocular pain or hypopyon. The patient was diagnosed with noninfectious endophthalmitis and successfully treated with topical antibiotics and topical steroid eye drops. The infection was apparently cleared at 3 days. At 10 days after the initial presentation, his vision loss resolved completely. CONCLUSIONS: Noninfectious endophthalmitis after intravitreal injection of aflibercept can be treated with topical steroids.
